Who Pays for Confirmatory Testing or Follow-Up After an Incidental Finding?

The Finding May Be Free to Discover, but What Happens When Follow-Up Costs Money?

A research scan reveals a suspicious abnormality. Before telling the participant that it may be meaningful, a specialist needs to review the image. A genomic study identifies a potentially important variant, but confirmation using an appropriate clinical process is needed before it can responsibly be returned.

Then comes a practical question with significant ethical consequences: who pays?

The research team may need additional testing simply to determine whether it has a returnable finding. After disclosure, the participant may need diagnostic evaluation, counseling, surveillance, or treatment. These costs are not all ethically or operationally equivalent, and there is no universal rule assigning every one of them to the researcher or the participant.

Responsibility for the Finding Does Not Automatically Determine Responsibility for Every Cost

“Follow-Up Costs” Actually Include Several Different Expenses

First separate research confirmation from clinical follow-up

The phrase “follow-up testing” can conceal several stages. Researchers may need additional work to determine whether an apparent finding is technically valid. They may then need expert interpretation to decide whether it meets the study's return threshold. Only after return might the participant enter ordinary clinical care for diagnosis, surveillance, prevention, or treatment.

Asking “Who pays?” without distinguishing these stages makes the problem look simpler than it is.

If confirmation is necessary for the research team to return the finding responsibly, it should be planned as part of the return process

Researchers should be cautious about designing a return policy that promises participants meaningful individual findings while having no mechanism or resources to establish whether those findings are reliable.

Canadian TCPS guidance on material incidental findings explicitly tells researchers and research ethics boards to consider whether appropriate resources are available, including resources to cover the cost of confirming the materiality of a finding where possible. It places this question within prospective planning for managing foreseeable incidental findings.

This does not create a universal legal rule that every research project must finance every confirmatory test. It does support a practical principle: if confirmation is integral to the study's own process for determining whether it has something responsible to disclose, its resource requirements should be addressed during study design rather than silently transferred to the participant after discovery.

Research confirmation and clinical diagnosis are not necessarily the same thing

A participant may receive a confirmed research result and still require additional clinical evaluation. Conversely, the research team may use a clinically appropriate confirmatory process before returning a finding.

NHGRI's current Secondary Genomics Findings Service provides a concrete example. Possible actionable secondary variants found in research exome or genome data are clinically confirmed before return, and the service coordinates confirmatory samples, genetic counseling, and disclosure. Its operational guidance also identifies particular costs and logistical responsibilities, including support for confirmatory sample shipping while participating research teams are responsible for arranging or supporting participant travel if they request in-person return at the NIH Clinical Center.

This example illustrates why cost allocation is often specific to the research program rather than governed by one general rule.

Clinical care after disclosure can fall outside the research budget

Once a participant has been appropriately informed and referred for clinical evaluation, subsequent healthcare may be governed by the ordinary healthcare system rather than the research study.

A research team's ethical responsibility to communicate or refer does not automatically make it financially responsible for every consultation, diagnostic procedure, surveillance test, or treatment that follows. Research is not generally designed to provide comprehensive medical care.

At the same time, researchers should consider whether a return policy creates predictable downstream burdens for participants. A study that deliberately returns findings requiring expensive confirmation while saying nothing about those likely costs may leave participants poorly prepared for the consequences of accepting results.

Do not confuse research-related injury with incidental clinical follow-up

A cost caused by a research procedure injuring a participant is conceptually different from a healthcare cost arising because research happened to reveal a pre-existing condition.

For research involving more than minimal risk, U.S. informed-consent requirements include information about whether compensation and medical treatment are available if research-related injury occurs. Those provisions do not mean that every medical expense following discovery of an unrelated condition is a research injury.

Researchers should therefore avoid importing compensation rules for research-related harm directly into the incidental-findings context without checking the applicable institutional and legal framework.

Participant insurance is not a complete ethical plan

A protocol may anticipate that subsequent clinical evaluation will occur through a participant's usual healthcare arrangements. But access to insurance or public healthcare is not uniform, and even insured participants can face deductibles, exclusions, travel costs, lost work time, or services that are not covered.

The National Academies has emphasized that returning individual research results creates costs and burdens for the research enterprise that need to be considered alongside participant value and feasibility. NHGRI similarly notes that return infrastructure and resources are major challenges, particularly as genomic data and potential findings increase.

The ethical issue is therefore not solved simply by writing “follow up with your doctor” into a disclosure letter.

Cost can influence whether a return program is feasible, but it should not be hidden

Research resources are finite. Specialist review, confirmation, counseling, recontact, and communication all consume money and personnel. The National Academies notes that resources for biomedical research require responsible stewardship and that returning individual results necessarily diverts some resources from research's primary objective of generating generalizable knowledge.

This means a research team can legitimately consider feasibility when deciding what categories of findings it can responsibly return. What it should not do is promise a broad return program without budgeting for the steps needed to make that program scientifically and ethically credible.

The first is responsible resource planning. The second is a protocol-design problem wearing a price tag.

Participants should know foreseeable financial implications

If receiving an incidental finding could predictably require participant-funded clinical follow-up, that possibility may matter to an informed decision about whether to receive the finding.

The exact level of detail appropriate for consent depends on the study. Researchers may not be able to predict every future medical cost, but they should avoid creating the impression that accepting a finding guarantees free confirmation, treatment, or lifelong follow-up when it does not.

NHGRI recommends articulating the return-of-results plan at the outset and explaining when and how results will be returned. A well-designed plan should likewise clarify the boundaries between what the research program provides and what happens after referral.

Do not make payment a condition for receiving information the study has already committed to return

If a study's approved protocol states that qualifying findings will be confirmed and returned, researchers should ensure that the operational model can support that commitment. Requiring an unexpected participant payment midway through the process can undermine the consent arrangement and create inequitable access to information.

This is especially concerning if participants with greater financial resources can receive validated findings while others receive only ambiguous preliminary warnings.

Cost questions should be separated from the question of who communicates the finding

A study may need specialist involvement even when that expertise carries additional cost. The fact that the principal investigator can contact the participant at no additional charge does not make the principal investigator the appropriate person to explain a complex medical result.

Budgeting should therefore reflect the communication model established for explaining incidental findings to participants, including any counseling or specialist expertise required.

A Genomic Finding Needs Confirmation Before Return

The important point is not that this allocation is universally correct. It is that the boundary was defined prospectively, reviewed, communicated, and supported rather than invented after the participant's result appeared.

Common Mistakes About Paying for Follow-Up

Draw the Financial Boundary Before Data Collection Begins

If your study could generate returnable incidental findings, map the entire pathway from preliminary observation to clinical handoff and attach likely costs to each stage. Then determine who is responsible for each one.

A return policy is financially credible only when researchers know not just what they intend to tell participants, but how they will get from a preliminary observation to information responsible enough to tell them.

Before Budgeting for Incidental Findings

Questions About Costs After an Incidental Finding

Plan the Cost of Knowing Before You Promise to Tell

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.